Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F van Harskamp

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Lancet (London, England)|July 4, 1998
Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam StudyA Ott, A J Slooter, A Hofman, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 11, 1998
Abnormal amino acid metabolism in patients with early stage Alzheimer dementiaD Fekkes, T J van der Cammen, C P van Loon, et al.
Clinical Neuropharmacology|June 9, 1998
Lisuride treatment of Alzheimer's disease. A preliminary placebo-controlled clinical trial of safety and therapeutic efficacyJ J Claus, I de Koning, F van Harskamp, et al.
Neurology|March 1, 1994
The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: a population-based studyJ J Claus, F van Harskamp, M M Breteler, et al.
Journal of Neurology|August 21, 2003
Linguistic deficits in the acute phase of strokeS J C Doesborgh, W M E van de Sandt-Koenderman, D W J Dippel, et al.
Stroke|June 1, 1994
Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam StudyM M Breteler, N M van Amerongen, J C van Swieten, et al.
Neurobiology of Aging|April 30, 1998
Regional cerebral blood flow and cerebrovascular risk factors in the elderly populationJ J Claus, M M Breteler, D Hasan, et al.
Journal of Neurology|June 15, 1999
Apolipoprotein E genotype and progression of Alzheimer's disease: the Rotterdam StudyA J Slooter, J J Houwing-Duistermaat, F van Harskamp, et al.
European Journal of Nuclear Medicine|June 1, 1996
Vascular risk factors, atherosclerosis, cerebral white matter lesions and cerebral perfusion in a population-based studyJ J Claus, M M Breteler, D Hasan, et al.
Lancet (London, England)|January 18, 1997
Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam StudyA Hofman, A Ott, M M Breteler, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|July 4, 1998
Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam StudyA Ott, A J Slooter, A Hofman, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 11, 1998
Abnormal amino acid metabolism in patients with early stage Alzheimer dementiaD Fekkes, T J van der Cammen, C P van Loon, et al.
Clinical Neuropharmacology|June 9, 1998
Lisuride treatment of Alzheimer's disease. A preliminary placebo-controlled clinical trial of safety and therapeutic efficacyJ J Claus, I de Koning, F van Harskamp, et al.
Neurology|March 1, 1994
The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: a population-based studyJ J Claus, F van Harskamp, M M Breteler, et al.
Journal of Neurology|August 21, 2003
Linguistic deficits in the acute phase of strokeS J C Doesborgh, W M E van de Sandt-Koenderman, D W J Dippel, et al.
Stroke|June 1, 1994
Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam StudyM M Breteler, N M van Amerongen, J C van Swieten, et al.
Neurobiology of Aging|April 30, 1998
Regional cerebral blood flow and cerebrovascular risk factors in the elderly populationJ J Claus, M M Breteler, D Hasan, et al.
Journal of Neurology|June 15, 1999
Apolipoprotein E genotype and progression of Alzheimer's disease: the Rotterdam StudyA J Slooter, J J Houwing-Duistermaat, F van Harskamp, et al.
European Journal of Nuclear Medicine|June 1, 1996
Vascular risk factors, atherosclerosis, cerebral white matter lesions and cerebral perfusion in a population-based studyJ J Claus, M M Breteler, D Hasan, et al.
Lancet (London, England)|January 18, 1997
Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam StudyA Hofman, A Ott, M M Breteler, et al.
Pageof 5